Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,948,418 | $3,932,198 | $4,282,551 | $4,473,532 |
| - Cash | $49,250 | $46,114 | $29,306 | $27,186 |
| + Debt | $0 | $129,299 | $0 | $114,410 |
| Enterprise Value | $3,899,168 | $4,015,383 | $4,253,245 | $4,560,756 |
| Revenue | $210,473 | $159,698 | $154,892 | $199,137 |
| % Growth | 31.8% | 3.1% | -22.2% | – |
| Gross Profit | $147,813 | $105,285 | $90,398 | $108,412 |
| % Margin | 70.2% | 65.9% | 58.4% | 54.4% |
| EBITDA | $83,922 | $31,080 | $30,145 | $32,691 |
| % Margin | 39.9% | 19.5% | 19.5% | 16.4% |
| Net Income | $58,029 | $21,635 | $18,101 | $23,389 |
| % Margin | 27.6% | 13.5% | 11.7% | 11.7% |
| EPS Diluted | 1.13 | 0.42 | 0.35 | 1.81 |
| % Growth | 169% | 20% | -80.7% | – |
| Operating Cash Flow | $73,373 | $9,180 | $18,844 | $73,122 |
| Capital Expenditures | -$17,622 | -$12,563 | -$8,275 | -$28,392 |
| Free Cash Flow | $55,751 | -$3,383 | $10,569 | $44,730 |